Page last updated: 2024-10-30

memantine and Feeding and Eating Disorders

memantine has been researched along with Feeding and Eating Disorders in 2 studies

Feeding and Eating Disorders: A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.

Research Excerpts

ExcerptRelevanceReference
"Memantine treatment was able both to reverse the memory deficits and to reduce the excessive intake of palatable diet and the withdrawal-induced hypophagia in food cycling rats."1.56Withdrawal from Extended, Intermittent Access to A Highly Palatable Diet Impairs Hippocampal Memory Function and Neurogenesis: Effects of Memantine. ( Abdullatif, AA; Cottone, P; Ferragud, A; Sabino, V; Velázquez-Sánchez, C, 2020)
"Memantine treatment markedly decreased appetite within few hours and complete suppressed the binge-eating disorder within 24 h."1.33A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders. ( Hermanussen, M; Tresguerres, JA, 2005)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ferragud, A1
Velázquez-Sánchez, C1
Abdullatif, AA1
Sabino, V1
Cottone, P1
Hermanussen, M1
Tresguerres, JA1

Other Studies

2 other studies available for memantine and Feeding and Eating Disorders

ArticleYear
Withdrawal from Extended, Intermittent Access to A Highly Palatable Diet Impairs Hippocampal Memory Function and Neurogenesis: Effects of Memantine.
    Nutrients, 2020, May-23, Volume: 12, Issue:5

    Topics: Animals; Behavior, Animal; Body Weight; Diet; Disease Models, Animal; Eating; Feeding and Eating Dis

2020
A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders.
    Economics and human biology, 2005, Volume: 3, Issue:2

    Topics: Adult; Anti-Obesity Agents; Calcium Channel Blockers; Calcium Channels; Excitatory Amino Acid Antago

2005